Figure 2.
The emerging role of PRAT in renal and cardiovascular homeostatic function. Metabolic dysfunction triggers PRAT deposition and inflammation leading to alterations in cardiovascular and renal function, triggering nephrotoxicity and cardiovascular diseases. CIMT, carotid intima-media thickness; CVD, cardiovascular disease; FFA, free fatty acid; GFR, glomerular filtration rate; IL-1β, interleukin-1 beta; NO, nitric oxide; RAS, renin angiotensin system; TNFα, tumor necrosis factor alpha; VEGF, vascular endothelial growth factor.